FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2/Neu Negative|Progesterone Receptor Negative|Progesterone Receptor Positive|Stage IV Breast Cancer AJCC v6 and v7
Interventions: PROCEDURE: Computed Tomography|DRUG: F-18 16 Alpha-Fluoroestradiol|OTHER: Laboratory Biomarker Analysis|PROCEDURE: Positron Emission Tomography
Sponsor: National Cancer Institute (NCI)